Archived App
This is an archived listing of the app previously available on the App Store.
This app helps healthcare professionals evaluate cardiovascular risk in patients using the SCORE tool. It also provides several other essential calculators for managing cardiovascular diseases.
1.2
April 12, 2016
This app has been updated by Apple to display the Apple Watch app icon. Added several new tools! - Vancouver Chest Pain Rules - Mean arterial pressure - LDL cholesterol estimation - ORBIT-AF score - PE Severity Index Improvements in User Interface Bug corrections
MoreHi, I don't really understand the meaning of your comment. However if you experience issues using the app, you can contact me on my website or on social medias. Best regards
Cardio SCORE is used by healthcare professionals to evaluate global cardiovascular risk in patients, primarily utilizing the SCORE tool developed by the European Society of Cardiology. It also includes various other calculators for managing cardiovascular conditions.
Cardio SCORE is specifically designed for healthcare professionals such as General Practitioners (GPs), cardiologists, and medical students who need tools for patient risk assessment and cardiovascular disease management.
Cardio SCORE includes the ABCD2 score for stroke risk after TIA, CHA2DS2 VASc for stroke risk in non-valvular atrial fibrillation patients, PE probability score, and HAS BLED score for bleeding risk in patients on anticoagulation.
Yes, Cardio SCORE is supported on iPhone, iPad, and iPod devices, making it accessible for professionals on various Apple platforms.
The app was last updated on April 12, 2016, to version 1.2. It was initially released on March 5, 2016. Future updates may include additional tools based on user suggestions.
Cardio SCORE is a paid application, available for a one-time purchase of $0.99.
Cardio SCORE has an age rating of 17+, indicating it is intended for mature audiences due to its clinical and medical content.
The provided data does not specify whether Cardio SCORE contains advertisements. However, given its paid nature and focus on professional use, it is unlikely to be ad-supported.
